Matthew Bugg
About Matthew Bugg
Matthew Bugg is the Quality Manager for Australia and New Zealand at BeiGene, based in Sydney, with over 18 years of experience in the pharmaceutical industry.
Title
Matthew Bugg holds the position of Quality Manager Australia and New Zealand at BeiGene, where he is responsible for ensuring quality standards in the region.
Professional Experience
Matthew Bugg has accumulated over 18 years of experience in the pharmaceutical industry. His previous roles include Quality Systems Manager (Sterile Manufacturing) at AstraZeneca, Quality Process & Training Manager at Roche, and Operational Quality Lead at GSK. Additionally, he served as Senior Quality Compliance Executive at Amco, Aseptic Compounding Team Leader at Cardinal Health, and Pharmacy Technician Manufacturing at The Ipswich Hospital NHS Trust.
Education and Expertise
Matthew Bugg has a Master’s Degree in Pharmaceutical Technology & Quality Assurance from the University of Leeds. He also holds a Pharmacy Degree from Birkbeck, University of London, and has studied at the University of Suffolk where he achieved a BTech National Diploma in Pharmaceutical Sciences and an NVQ Level III in Pharmacy Services.
Specializations and Skills
Specializing in both sterile and non-sterile manufacturing, Matthew Bugg is well-versed in regulatory guidelines including PIC/s, TGA, MHRA, CFDA, ICH, ISO, PDA, and WHO. He has expertise in aseptic, BFS, and H2020 Isolator technology and is skilled in managing QMS systems including annual product quality review, OOS management, data integrity, CAPA, change control, validation, and quality risk management. Matthew is proficient in GxP auditing and preparing for regulatory inspections.
Regulatory Knowledge
Matthew Bugg has extensive knowledge of international standards such as 21 CFR part 11, 58, 210, 211, ISO 9001, 13485, 17025, and EU Vol. 4-Annex 11. His experience covers contamination control, warehousing, and distribution, as well as managing clinical GMP quality activities including temperature excursions, product complaints, deviations, audit preparedness, and third-party contract manufacturing vendors.